Bcr-Abl inhibition as a modality of CML therapeutics (Q34366423)
scientific article
Language:
Current Data About Bcr-Abl inhibition as a modality of CML therapeutics
(P31) (Q13442814)
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

(Q7318358)
(P248)

(P304) M11-8
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

(P407) (Q1860)

(P433) 1
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

(P478) 1551
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

(P577) Wednesday, August 1, 2001
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

(P1433) (Q864239)
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

(P1476) "Bcr-Abl inhibition as a modality of CML therapeutics" (language: en)
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

(P2093) E Buchdunger
(P1545) 1
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

A Matter
(P1545) 2
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

B J Druker
(P1545) 3
(P248)
(P698) 11553417
(P813) Tuesday, August 1, 2017

(P2860) (Q33603077)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q33700942)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q29614339)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q59080605)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q59064021)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q43900370)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q48329182)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q41743756)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q46334847)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q33764518)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q55033528)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q41740883)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q28277030)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q41056381)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q59831038)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q77922880)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q74083395)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q73030493)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q73088370)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q33889677)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

(Q27627097)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0304-419X%2801%2900022-1
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S0304-419X(01)00022-1
(P698) 11553417
(P5875) 11795090